Berg T - Search Results

1

Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.

van Bömmel F, de Man RA, Wedemeyer H, Deterding K, Petersen J, Buggisch P, Erhardt A, Hüppe D, Stein K, Trojan J, Sarrazin C, Böcher WO, Spengler U, Wasmuth HE, Reinders JG, Möller B, Rhode P, Feucht HH, Wiedenmann B, Berg T. van Bömmel F, et al. Among authors: berg t. Hepatology. 2010 Jan;51(1):73-80. doi: 10.1002/hep.23246. Hepatology. 2010. PMID: 19998272

2

Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.

Hopf U, Berg T, König V, Küther S, Heuft HG, Lobeck H. Hopf U, et al. Among authors: berg t. J Hepatol. 1996;24(2 Suppl):67-73. J Hepatol. 1996. PMID: 8836892 Clinical Trial.

3

Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions.

Fukumoto T, Berg T, Ku Y, Bechstein WO, Knoop M, Lemmens HP, Lobeck H, Hopf U, Neuhaus P. Fukumoto T, et al. Among authors: berg t. Hepatology. 1996 Dec;24(6):1351-4. doi: 10.1002/hep.510240606. Hepatology. 1996. PMID: 8938160

4

Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus.

Berg T, Dirla U, Naumann U, Heuft HG, Küther S, Lobeck H, Schreier E, Hopf U. Berg T, et al. J Hepatol. 1996 Nov;25(5):763-8. doi: 10.1016/s0168-8278(96)80250-9. J Hepatol. 1996. PMID: 8938557 Clinical Trial.

5

Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation.

Haller GW, Bechstein WO, Neuhaus R, Raakow R, Berg T, Hopf U, Neuhaus P. Haller GW, et al. Among authors: berg t. Transpl Int. 1996;9 Suppl 1:S210-2. doi: 10.1007/978-3-662-00818-8_53. Transpl Int. 1996. PMID: 8959829

6

Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters.

Berg T, Hopf U, Stark K, Baumgarten R, Lobeck H, Schreier E. Berg T, et al. J Hepatol. 1997 Mar;26(3):484-91. doi: 10.1016/s0168-8278(97)80411-4. J Hepatol. 1997. PMID: 9075653

7

A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis.

Naumann U, Protzer-Knolle U, Berg T, Leder K, Lobeck H, Bechstein WO, Gerken G, Hopf U, Neuhaus P. Naumann U, et al. Among authors: berg t. Hepatology. 1997 Aug;26(2):478-84. doi: 10.1002/hep.510260232. Hepatology. 1997. PMID: 9252162

8

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation.

Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Büschenfelde KH, Neuhaus P, Gerken G. Protzer-Knolle U, et al. Among authors: berg t. Hepatology. 1998 Jan;27(1):254-63. doi: 10.1002/hep.510270138. Hepatology. 1998. PMID: 9425945

9

Long-term efficacy of interferon alpha treatment in chronic hepatitis C.

Berg T, Kaul T, Heuft HG, Naumann U, Lobeck H, Wiedenmann B, Hopf U. Berg T, et al. J Hepatol. 1998 Sep;29(3):511-2. doi: 10.1016/s0168-8278(98)80076-7. J Hepatol. 1998. PMID: 9765005 Clinical Trial. No abstract available.

10

Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication.

Berg T, Müller AR, Platz KP, Höhne M, Bechstein WO, Hopf U, Wiedenmann B, Neuhaus P, Schreier E. Berg T, et al. Hepatology. 1999 Jan;29(1):245-9. doi: 10.1002/hep.510290121. Hepatology. 1999. PMID: 9862873 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,264 results

Search Page

Filters